ASH2L Antibodies

Santa Cruz Biotechnology provides a broad selection of ASH2L monoclonal antibodies for various research applications. ASH2L monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ASH2L, or ASH2-like protein, plays a critical role in the regulation of gene expression and is a key component of the MLL (Mixed-Lineage Leukemia) complex, which is essential for proper hematopoiesis and development. Dysregulation of ASH2L has been implicated in various cancers, making it a significant target for therapeutic research. Understanding the function of ASH2L is crucial for elucidating the mechanisms of epigenetic regulation and its impact on cellular processes. ASH2L monoclonal antibodies enable researchers to investigate protein expression patterns across different tissue types and experimental conditions. Studying ASH2L interactions with other proteins provides insights into complex cellular signaling networks and regulatory pathways. ASH2L monoclonal antibodies support cutting-edge research in epigenetics, cancer biology, and developmental studies, advancing our understanding of fundamental biological processes.